ABOUT THIS EPISODE
Sep 7, 2026 – Boston College’s Dr. Thomas Seyfried tells Financial Sense Newshour’s Jim Puplava why he believes cancer is a mitochondrial metabolic disease—not primarily a genetic one. He explains why conventional treatments may miss the real driver...
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Financial Sense Newshour.
OTHER EPISODES IN THIS PODCAST
Oct 8, 2026 – Bond yields are back to levels not seen since 2002, and Greg Weldon says the chaos is only beginning. Jim Puplava sits down with the veteran trader and author of Gold Trading Boot Camp to unpack a world under pressure from every angle...
Oct 9, 2026 – The S&P 500 keeps hitting new highs while most of its stocks quietly crash. Jim Puplava sits down with Jeffrey Huge, chief investment officer at JWH Investment Partners, to unpack a market that is overconcentrated, overvalued, overleveraged, and over-owned...
Oct 9, 2026 – There's a disagreement developing in the markets that I think investors need to pay attention to, particularly if they've benefited from the tremendous rally in artificial intelligence stocks. Credit markets are becoming increasingly concerned...
Oct 7, 2026 – Is Greenland the blueprint for a new American geopolitical strategy? Edward Gustely joins FS Insider's Cris Sheridan to explore how strategic access strengthens U.S. positioning in the Arctic and counter China’s influence...
Oct 5, 2026 – What does it take for a family business to survive beyond the founder? Brendan McMurtrie and Ryan Puplava explore the essential challenges of business succession planning, using the Anheuser-Busch sale as a compelling case study of...
Disclaimer: The podcast and artwork embedded on this page are from Financial Sense, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
